176 results on '"Hare, C. Bradley"'
Search Results
2. Factors associated with suicidal ideation among people with HIV engaged in care
3. Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic
4. Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care
5. Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV
6. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
7. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017
8. HIV Stigma and Its Associations with Longitudinal Health Outcomes Among Persons Living with HIV with a History of Unhealthy Alcohol Use
9. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial
10. Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study
11. Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial
12. Cardiovascular Disease Risk Factor Control in People With and Without HIV.
13. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
14. Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting
15. Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care.
16. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings
17. A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive Patients
18. The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels Among HIV-Infected Patients Entering Care With a CD4 Count Greater Than 500/μL, in a Public Health Setting
19. Low Rates of Hepatitis Screening and Vaccination of HIV-Infected MSM in HIV Clinics
20. The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologie Set Point in Recently HIV-1-Infected Individuals
21. The Effect of AIDS Clinical Trials Group Protocol 5164 on the Time From Pneumocystis jirovecii Pneumonia Diagnosis to Antiretroviral Initiation in Routine Clinical Practice: A Case Study of Diffusion, Dissemination, and Implementation
22. Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy
23. Reply to DiNubile
24. Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of VirologicaUy Suppressive Antiretroviral Therapy
25. Methamphetamine Use, Transmission Risk Behavior and Internet Use Among HIV-Infected Patients in Medical Care, San Francisco, 2008
26. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection
27. Primary HIV infection
28. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
29. Personal health records in a public hospital: experience at the HIV/AIDS clinic at San Francisco General Hospital
30. Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents
31. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection
32. Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis
33. Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft
34. The Deadliest Catch: Fishing for HIV in New Waters
35. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts
36. Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
37. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006–2007
38. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence
39. Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens.
40. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV.
41. Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco.
42. The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1–Infected Individuals
43. Differences in HIV Burden and Immune Activation within the Gut of HIV+ Patients on Suppressive Antiretroviral Therapy
44. Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter
45. Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco.
46. HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis.
47. Leveraging a Rapid, Round-the-Clock HIV Testing System to Screen for Acute HIV Infection in a Large Urban Public Medical Center.
48. Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV-Coinfected Adults With Persistent HBV Viremia.
49. Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic.
50. Testing and Linkage to Care Outcomes for a Clinician-Initiated Rapid HIV Testing Program in an Urban Emergency Department.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.